Back    Zoom +    Zoom -
<Research>Daiwa: WUXI BIO (02269.HK) Sees Significant Gross Margin Improvement; 2H25 NP Forecast Beats
Recommend
10
Positive
8
Negative
3
WUXI BIO (02269.HK) recently issued a positive profit alert projecting that its 2025 revenue will rise by 16.7% YoY to RMB21.79 billion, Daiwa published a research report saying. This implies a 2H25 revenue of approx. RMB11.8 billion, in line with forecasts.

2025 gross margin is expected to expand by about 5 ppts YoY to 46%, ahead of the broker's forecast of 44%. 2H25 net profit is estimated to be RMB2.569 billion, 9% higher than Daiwa's prediction. Therefore, Daiwa rated WUXI BIO at Buy.

Related NewsNomura Elevates WUXI BIO (02269.HK) TP to $50.54 as Preliminary 2025 Results Beat

AASTOCKS Financial News
Website: www.aastocks.com